We are live on ! Find out more
IBRX icon

ImmunityBio
IBRX

68 hedge funds and large institutions have $92.1M invested in ImmunityBio in 2016 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 20 increasing their positions, 15 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 8

33% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 15

19.55% more ownership

Funds ownership: 0% → 19.55% (+20%)

8% more funds holding

Funds holding: 63 → 68 (+5)

1% more call options, than puts

Call options by funds: $80K | Put options by funds: $79K

41% less capital invested

Capital invested by funds: $155M → $92.1M (-$62.8M)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
68
Holders Change
+5
Holders Change %
+7.94%
% of All Funds
1.7%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
14
Increased
20
Reduced
15
Closed
8
Calls
$80K
Puts
$79K
Net Calls
+$1K
Net Calls Change
-$812K

Top Buyers

1
Millennium Management
Millennium Management
New York
+$970K
2
BFA
BlackRock Fund Advisors
California
+$946K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$587K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$354K
5
Morgan Stanley
Morgan Stanley
New York
+$327K

Top Sellers

1
CC
Callan Capital
California
-$26.5M
2
Franklin Resources
Franklin Resources
California
-$6.21M
3
Bank of America
Bank of America
North Carolina
-$960K
4
ACA
Avoro Capital Advisors
New York
-$563K
5
VEA
Virtus ETF Advisers
New York
-$295K
Name Holding Trade Value Shares
Change 		Change in
Stake
TI
26
Trexquant Investment
Connecticut
$209K +$244K +36,593 New
California State Teachers Retirement System (CalSTRS)
27
California State Teachers Retirement System (CalSTRS)
California
$197K -$6K -900 -3%
AllianceBernstein
28
AllianceBernstein
Tennessee
$178K – – –
SG Americas Securities
29
SG Americas Securities
New York
$164K +$191K +28,675 New
CS
30
Credit Suisse
Switzerland
$142K -$9.75K -1,462 -6%
Renaissance Technologies
31
Renaissance Technologies
New York
$140K +$163K +24,500 New
ACM
32
Akanthos Capital Management
California
$135K – – –
Wells Fargo
33
Wells Fargo
California
$134K -$42.6K -6,380 -21%
Citigroup
34
Citigroup
New York
$127K +$48K +7,195 +48%
ARTA
35
A.R.T. Advisors
New York
$124K +$145K +21,700 New
DTL
36
Dynamic Technology Lab
Singapore
$123K +$70.4K +10,551 +97%
MAM
37
Martingale Asset Management
Massachusetts
$111K – – –
Citadel Advisors
38
Citadel Advisors
Florida
$106K +$123K +18,477 New
New York State Common Retirement Fund
39
New York State Common Retirement Fund
New York
$102K – – –
Tudor Investment Corp
40
Tudor Investment Corp
Connecticut
$102K +$119K +17,912 New
RhumbLine Advisers
41
RhumbLine Advisers
Massachusetts
$95K +$4.92K +737 +5%
VKH
42
Virtu KCG Holdings
New York
$94K +$14.6K +2,189 +15%
OAC
43
OMERS Administration Corp
Ontario, Canada
$80K +$92.7K +13,900 New
ADL
44
Asset Dedication LLC
California
$76K – – –
Deutsche Bank
45
Deutsche Bank
Germany
$69K -$44.7K -6,700 -35%
Canada Life
46
Canada Life
Manitoba, Canada
$63K +$73.6K +11,036 New
NFA
47
Nationwide Fund Advisors
Ohio
$59K – – –
BA
48
BlackRock Advisors
Delaware
$55K -$4.01K -601 -6%
AIG
49
American International Group
New York
$55K -$167 -25 -0.3%
Creative Planning
50
Creative Planning
Kansas
$42K +$45.4K +6,800 +1,360%
1
2
3

IBRX Hedge Fund Activity: Q4 2016 in Review

68 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in ImmunityBio (IBRX) for Q4 2016, worth a combined $92.1M — down 41% from $155M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new IBRX positions and 8 closed out — a net gain of 6 holders — while 20 added to existing stakes and 15 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $970K. The largest seller was Callan Capital, exiting entirely with an estimated $26.5M sold.

  • 68 institutional investors held ImmunityBio (IBRX) as of Q4 2016, up from 63 in Q3 2016.
  • Funds reported $92.1M of ImmunityBio stock for Q4 2016, down 41% quarter-over-quarter.
  • 14 funds opened new ImmunityBio positions in Q4 2016 and 8 closed out, a net change of +6 holders.
  • The largest ImmunityBio buyer in Q4 2016 was Millennium Management, an estimated $970K added.
  • The largest ImmunityBio seller in Q4 2016 was Callan Capital, an estimated $26.5M sold.

Based on aggregated 13F filings for Q4 2016.